Virbac Corporation – FDA 483, Jul 28, 2023

Virbac Corporation in Bridgeton, MO, was inspected from July 24-28, 2023, and received a Form 483 for failing to establish and follow appropriate written procedures to prevent objectionable microorganisms in non-sterile drug products. Inspectors observed leaking water systems and standing water in the warehouse, along with mineral deposits, indicating a lack of environmental control. The firm also lacked written procedures for monitoring these water systems for leaks.